glutathione mast cell cells are hypersensitive immune cells that release histamine and other inflammatory mediators—often in response to oxidative stress, environmental toxins, and immune imbalance. Many patients with MCAS have low levels of Mast Cell: A Multi-Functional Master

This time it's kind of a sad one rather than a fun one

Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study

Currently under clinical investigation , cagrilintide is being evaluated both as a standalone treatment and in combination with semaglutide

Glutathione-responsive nanosystems are engineered to remain stable in circulation but undergo structural changes or drug release specifically in high-GSH tumor cells, improving therapeutic precision and reducing off-target toxicity

Injectable use in humans represents off-label experimental application with limited long-term human safety data specifically for injectable formulations